Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients

Serum serotonin as unexpected potential marker for staging of experimental hepatocellular carcinoma

(2016) N.M. Abdel-Hamid et al.   BIOMEDICINE & PHARMACOTHERAPY

Platelet serotonin modulates immune functions

(2015) M. Mauler et al.   Hamostaseologie

Serotonin: A Different Player in Hypertension-Associated Thrombosis

(2015) M. Fraer et al.   HYPERTENSION

5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1/β-catenin/MMP-7 signaling pathway

(2015) Hua Sui et al.   Oncotarget

5-Hydroxytryptamine (serotonin) in the gastrointestinal tract

(2013) Michael D. Gershon   Current Opinion in Endocrinology Diabetes and Obesity

Serotonin paracrine signaling in tissue fibrosis

(2012) Derek A. Mann et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Serotonin activates angiogenic phosphorylation signaling in human endothelial cells

(2012) Ali Zamani et al.   FEBS LETTERS

β-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer

(2012) E R M Bakker et al.   ONCOGENE

The Measurement of Platelet-Poor Plasma Serotonin:A Systematic Review of Prior Reports and Recommendations for Improved Analysis

(2011) T. Brand et al.   CLINICAL CHEMISTRY

Serotonin promotes tumor growth in human hepatocellular cancer

(2009) Christopher Soll et al.   HEPATOLOGY

Serotonin Regulates Macrophage-Mediated Angiogenesis in a Mouse Model of Colon Cancer Allografts

(2008) A. Nocito et al.   CANCER RESEARCH

Serotonin used as prognostic marker of urological tumors

(2008) Nina Jungwirth et al.   WORLD JOURNAL OF UROLOGY